Eidos Therapeutics, Inc.

MARSHALL WACE, LLP
Report date
12/31/2020
Quarter
2020 Q4
Filed
2/16/2021
Shares
2,403
Value ($000)
316
Weight
0.0%
2020 Q4 - 2020 Q4 (1 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).